| Product Name | Pidilizumab (Anti-PDCD1 / PD-1 / CD279) |
|---|---|
| CAS | 1036730-42-3 |
| Size | Availability | Price(USD) | VIP Price (USD) | Quantity |
|---|---|---|---|---|
| 1 mg | 3-5days | ¥3600.00 | Visible after login | |
| 5 mg | 3-5days | ¥15500.00 | Visible after login | |
| 10 mg | 3-5days | ¥28500.00 | Visible after login | |
| 50 mg | 3-5days | ¥126000.00 | Visible after login | |
| 100 mg | 3-5days | ¥235000.00 | Visible after login |
| Product Name | Pidilizumab (Anti-PDCD1 / PD-1 / CD279) |
|---|---|
| CAS | 1036730-42-3 |
Pidilizumab (Anti-PDCD1 / PD-1 / CD279) is a humanized monoclonal antibody targeting human PD-1 (programmed cell death 1; PDCD1). It has immunomodulating and antitumor activities and can be used in treatment of metastatic melanoma. MW :144.48 KD.